Europe — EMA
Neuromiol (Rasagiline)
GNH USA supplies Neuromiol (Rasagiline), a monoamine oxidase B inhibitor for Parkinson's disease treatment. Request a quote for worldwide hospital supply.
Request sourcing
What is Rasagiline?
Rasagiline, the active ingredient in Neuromiol, is a monoamine oxidase B inhibitor presented as an oral tablet for oral use. It is indicated for the treatment of Parkinson's disease in adults. GNH USA supplies Neuromiol as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Rasagiline used for?
Neuromiol, a monoamine oxidase B inhibitor, is employed in the management of Parkinson's disease and related therapeutic pathways.
Parkinson's disease (early-stage): improves motor symptoms and delays disease progression. Parkinson's disease (adjunct to levodopa): reduces off‑time and enhances overall motor control. Parkinson's disease (maintenance therapy): helps sustain dopamine levels for long‑term symptom control.
What are the side effects of Rasagiline?
Neuromiol may cause a range of adverse reactions that vary in frequency and severity.
Common Side Effects: - Nausea - Headache - Dizziness - Insomnia
Serious or Rare Side Effects: - Hypertension (sudden increase in blood pressure) - Hallucinations or psychotic episodes - Serotonin syndrome when combined with serotonergic agents - Severe liver injury - Allergic reactions such as rash or angioedema
What precautions apply to Rasagiline?
When prescribing Neuromiol, clinicians should consider several safety measures. - Dose adjustment: required in patients with renal impairment. - Monitor blood pressure: the drug may cause hypertension. - Avoid use with selective MAO‑A inhibitors: risk of hypertensive crisis. - Assess psychiatric status: may exacerbate hallucinations or depression. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.
What does Rasagiline interact with?
Neuromiol can interact with several medication classes, requiring careful management.
Major Interactions (Avoid): - Selective MAO‑A inhibitors: risk of hypertensive crisis. - Serotonergic antidepressants (e.g., SSRIs, SNRIs): risk of serotonin syndrome.
Moderate Interactions (Monitor Closely): - Levodopa: may enhance hypotensive effects. - Antihypertensive agents: additive blood pressure lowering. - Anticholinergic drugs: may increase anticholinergic burden.
Frequently asked questions
What is Neuromiol used for?+
How does rasagiline work?+
What is the usual dose of Neuromiol?+
Is Neuromiol safe in pregnancy or breastfeeding?+
How do I order Neuromiol from GNH USA?+
How does Neuromiol compare with the main alternative drug or class?+
How should Neuromiol be stored and handled?+
How is Neuromiol administered?+
What are the most serious risks to watch for while taking Neuromiol?+
Who should not use Neuromiol?+
Product details
Related products

Rasagiline .5 mg/1
Rasagiline · 0.5 mg

Rasagiline 1 mg/1
Rasagiline · 1 mg

Rasagiline .5 mg/1
Rasagiline · 0.5 mg

Rasagiline 1 mg/1
Rasagiline · 1 mg